The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15477
StudyName: Baseline: Repitition of AssessmentsMSFC Multiple Sclerosis ALAIN01 NCT02419378
Date of export from the portal: 02.07.2020
Date of Upload / last change: 01.06.2016
License: Creative Commons BY 4.0

----

Description: 
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
https://clinicaltrials.gov/ct2/show/NCT02419378
Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany

Part: Baseline: Repitition of Assessments

Please complete the following pages only if Baseline Assessments
had to be repeated prior to initiation of Lemtrada® (relapse after first
examination, see Study Protocol 8.1.1.2)
